Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS SEPTEMBER ISSUE PUBLISHED
  • SEPTEMBER 2020 Issue has been successfully launched on 1 September 2020.

Abstract

HUMAN IMMUNODEFICIENCY VIRUS ASSOCIATED TUBERCULOSIS

Sereena Saju, PharmD*, A.S. Ezhilarasi, PharmD, Mancy Jose Mattam, PharmD, Mehnaaz Anjum. H, PharmD, M. Vani, M. Pharm., Ph.D., Meena, M. Pharm., Ph.D.

ABSTRACT

The association of tuberculosis (TB) with human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS) over the past many years has become a rising syndemic. Co-infection with HIV provokes challenges in identification and treatment of tuberculosis. Further, there has been a rise in rates of drug resistant TB, including multi-drug resistant TB (MDR-TB) and extensively drug resistant TB (XDRTB), which poses a troublesome in treatment thus, contributing to increased mortality. HIV complicates every aspects of TB including presentation, diagnosis and treatment. HIV-TB coinfected patients encounters distinctive issues like drug–drug interactions, additive toxicity, lower plasma drug levels, suboptimal adherence and emergence of drug resistance, particularly immune reconstitution inflammatory syndrome (IRIS). Moreover, poor performance of sputum smear microscopy resulted in inadequate diagnosis of HIV-infected patients, newer diagnostic measures are urgently needed that not only seem to be solely sensitive and specific, however, easy to use in remote and resource-constrained settings. Linkage of co-infected patients to antiretroviral treatment centres is crucial if early mortality is to be prevented. This review focuses on the epidemiology, etiology, pathophysiology, clinical aspects, diagnosis of HIV-associated TB and summarizes World Health Organisation (WHO) recommendations for treatment.

Keywords: Co-infection, Xpert MTB Rif, tuberculous granulomas, antiretroviral therapy, drug resistance, infection control.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More